The wise are snapping up the 38s......procrastinators will pay more than a DOLLAR after the IND. Pre-IND is the LAST chance to avoid PAYING UP. THE CATALYST NEWS CYCLE is about to start humming for SBFM. Everything we already understand about the fantastic science here BECOMES NEWSWORTHY and important to a HUGE NUMBER of media outlets that would never cover a biotech startup WITHOUT an IND. The IND alone puts MEAT ON THE TABLE. The TRIAL LAUNCH turns that table into a FEAST. Given importance of BREAST CANCER in society news about SBFMs progress will be impossible for any EDITOR to IGNORE.
Market Data 
Markets 
AI
